Press releases
- Press releases
- Browse
Press releases
Genesis 2010, Westminster, Thursday 9 December is on track to attract a larger than ever attendance to debate new medicines and healthcare products research. More
Cambridge, 4 November 2010 - One Nucleus, the not-for-profit membership company for international life science and healthcare companies, is to launch a series of high level conferences focused on specific technology areas, replacing its annual BioPartneri More
The U.S. FDA this week issued new guidelines for labeling of Non-Steroidal Anti-Inflammatory Drugs (NSAID) and Acetaminophen (Paracetemol) used for pain relief and fever reduction due to concerns about overdosing and co-administration with Alcohol. TDS wo More
tesa AG, based in Hamburg, has acquired Labtec Gesellschaft für technologische Forschung und Entwicklung mbH More
New summary from Partneringdesk highlights trends in dealmaking from the top pharma and biotech companies More
A dozen University of Western Ontario research projects, including ensuring innovative research on Metabolic Syndrome and personalized medicine, have received $19-million from the Ontario Research Fund. More
Pharmalicensing now offers in-depth and involved consulting to guide you through the process of licensing More
Morphochem names Alfred E. Seidel as CEO. Dr Seidel will drive strategic change at the Company as it advances its products into clinical development. More
With deals increasing in terms of number and value, partnering at early stage development is now an integral component of pharmaceutical and biotech business strategy. Pharmalicensing has revised and updated its successful Early Stage report More
Increasing numbers of companies within Taiwan's burgeoning life science industry space are parlaying Traditional Chinese Medicine (TCM) know-how into all the development of new drug candidates covering a wide range of unmet medical needs. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Aug 2008 - 120 pages - $1,040
Jan 2009 - $15,200
Jan 2011 - 99 pages - $3,835
Aug 2010 - 80 pages - $1,215
May 2011 - 43 pages - $500
Nov 2010 - 40 pages - $500
Feb 2011 - 209 pages - $3,500
Dec 2010 - 36 pages - $500
Sep 2010 - 412 pages - $1,040
Nov 2010 - 7 pages - $500
Your selection
Browse By
- Industry sector
- Bioinformatics
- Combinatorial biology
- Combinatorial chemistry
- Drug research platforms
- Genomics
- High throughput screening
- Proteomics
- Therapeutic target
- Acute coronary syndromes
- Anemia
- Anticoagulants
- Blood clotting
- Blood composition
- Cardiovascular disorder (other)
- Cerebrovascular disorders
- Thrombotic disorders
- Treatments
- Vascular
- Year
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000
- 1999
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us